CSIMarket
 


Cardiff Lexington Corporation  (CDIF)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

CDIF's Net Cash Flow Growth by Quarter and Year

Cardiff Lexington's Net Cash Flow results by quarter and year

 



CDIF Net Cash Flow (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December -0.76 0.69 -0.02 -0.62
III Quarter September -1.25 -0.23 -0.35 0.15
II Quarter June 1.94 0.06 0.07 0.55
I Quarter March 0.39 0.12 -0.06 0.23
FY   0.32 0.64 -0.36 0.31



CDIF Net Cash Flow fourth quarter 2024 Y/Y Growth Comment
Cardiff Lexington Corporation in the fourth quarter 2024 recorded net cash outflow of $ -0.76 millions.

Looking into fourth quarter 2024 results within Healthcare Facilities industry 5 other companies have achieved higher Net Cash Flow growth. While Cardiff Lexington Corporation' s Net Cash Flow no change of % ranks overall at the positon no. 371 in the fourth quarter 2024.




CDIF Net Cash Flow ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June 3133.33 % -14.29 % -87.27 % 77.42 %
I Quarter March 225 % - - -
FY   -50.22 % - - 55 %

Financial Statements
Cardiff Lexington's fourth quarter 2024 Net Cash Flow $ -0.76 millions CDIF's Income Statement
Cardiff Lexington's fourth quarter 2023 Net Cash Flow $ 0.69 millions Quarterly CDIF's Income Statement


CDIF Net Cash Flow (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - - - -
III Quarter September - - - -72.73 %
II Quarter June 397.44 % -50 % - 139.13 %
I Quarter March -43.48 % - - 360 %
FY (Year on Year)   -50.22 % - - 55 %




Net Cash Flow fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #6
Healthcare Sector #62
Overall #371

Net Cash Flow Y/Y Growth Statistics
High Average Low
823.55 % -159.23 % -1956.58 %
(Sep 30 2021)   (Dec 31 2018)
Net Cash Flow fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #6
Healthcare Sector #62
Overall #371
Net Cash Flow Y/Y Growth Statistics
High Average Low
823.55 % -159.23 % -1956.58 %
(Sep 30 2021)   (Dec 31 2018)

Net Cash Flow by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Cardiff Lexington's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDIF's IV. Quarter Q/Q Net Cash Flow Comment
Despite the fact, that Cardiff Lexington Corporation in the IV. Quarter 2024 revealed net cash outflow of $ -0.76 millions, some analyst point out, that those numbers show recovery compare to the -1.25 millions in the third quarter.

Within Healthcare Facilities industry Cardiff Lexington Corporation achieved highest sequential Net Cash Flow growth. While Cardiff Lexington's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CDIF's IV. Quarter Q/Q Net Cash Flow Comment
Even if Cardiff Lexington Corporation in the IV. Quarter 2024 showed net cash outflow of $ -0.76 millions, management said, that this are slight up side compare to the -1.25 millions in the third quarter.

Within Healthcare Facilities industry Cardiff Lexington Corporation achieved highest sequential Net Cash Flow growth. While Cardiff Lexington's Net Cash Flow growth quarter on quarter, overall rank is .


Cardiff Lexington's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2024)
12 Months Ending
(Sep 30 2024)
12 Months Ending
(Jun 30 2024)
12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
Cumulative Net Cash Flow 12 Months Ending $ 0.32 $ 1.78 $ 2.79 $ 0.91 $ 0.65
Y / Y Net Cash Flow Growth (TTM) -50.41 % - - - -
Year on Year Net Cash Flow Growth Overall Ranking # 596 # 0 # 0 # 0 # 0
Seqeuential Net Cash Flow Change (TTM) -81.91 % -36.42 % 206.64 % 40.61 % -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 371 # 396 # 368 # 244 # 0


Cumulative Net Cash Flow growth Comment
Cardiff Lexington showed decline, but improvement compare to trailing twelve month Net Cash Flow decrease in Sep 30 2024. If the fiscal year would end in Dec 31 2024, Cardiff Lexington's annual Net Cash Flow rise would be -50.41% year on year to $0 millions.

In the Healthcare sector 84 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 0 to 596.

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 6
Healthcare Sector # 85
Overall # 596

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
823.55 %
-159.23 %
-1956.58 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 62
S&P 500 # 371
Cumulative Net Cash Flow growth Comment
Cardiff Lexington showed decline, but improvement compare to trailing twelve month Net Cash Flow decrease in Sep 30 2024. If the fiscal year would end in Dec 31 2024, Cardiff Lexington's annual Net Cash Flow drop would be -50.41% year on year to $0 millions.

In the Healthcare sector 84 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 0 to 596.


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 6
Healthcare Sector # 85
Overall # 596

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
823.55 %
-159.23 %
-1956.58 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 62
S&P 500 # 371




Other Net Cash Flow Growth
Healthcare Facilities Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
CDIF's Net Cash Flow Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for CDIF's Competitors
Net Cash Flow Growth for Cardiff Lexington's Suppliers
Net Cash Flow Growth for CDIF's Customers

You may also want to know
CDIF's Annual Growth Rates CDIF's Profitability Ratios CDIF's Asset Turnover Ratio CDIF's Dividend Growth
CDIF's Roe CDIF's Valuation Ratios CDIF's Financial Strength Ratios CDIF's Dividend Payout Ratio
CDIF's Roa CDIF's Inventory Turnover Ratio CDIF's Growth Rates CDIF's Dividend Comparisons



Companies with similar Net Cash Flow drop for the quarter ending Dec 31 2024 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2024
Zoetis Inc -4.88%$ -4.878 millions
Nature s Sunshine Products inc -5.38%$ -5.381 millions
Lipella Pharmaceuticals Inc -5.97%$ -5.969 millions
Blueprint Medicines Corporation-8.23%$ -8.231 millions
Ati Physical Therapy Inc -8.51%$ -8.505 millions
Enliven Therapeutics Inc -10.64%$ -10.641 millions
Neurogene Inc -12.26%$ -12.260 millions
Maia Biotechnology Inc -12.96%$ -12.962 millions
Editas Medicine Inc -13.15%$ -13.146 millions
Globus Medical Inc -13.85%$ -13.854 millions
Iqvia Holdings Inc -14.47%$ -14.474 millions
In8bio Inc -15.47%$ -15.469 millions
Regeneron Pharmaceuticals Inc -17.38%$ -17.382 millions
Exact Sciences Corporation-18.94%$ -18.942 millions
Abeona Therapeutics Inc -21.82%$ -21.822 millions
Kezar Life Sciences Inc -23.39%$ -23.391 millions
Cvrx inc-23.81%$ -23.812 millions
Lemaitre Vascular Inc -25.88%$ -25.876 millions
Kazia Therapeutics Limited-28.80%$ -28.800 millions
Siga Technologies Inc-28.98%$ -28.977 millions
Electromed Inc -30.47%$ -30.469 millions
Protagenic Therapeutics Inc new-31.02%$ -31.016 millions
Zimvie Inc -31.20%$ -31.196 millions
Sanofi-31.61%$ -31.611 millions
Keros Therapeutics Inc -32.38%$ -32.383 millions
Envista Holdings Corporation-32.82%$ -32.815 millions
Enovis Corporation-34.12%$ -34.118 millions
Penumbra Inc-34.17%$ -34.170 millions
Teladoc Health Inc -36.48%$ -36.476 millions
Solid Biosciences Inc -36.50%$ -36.496 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com